| Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non–small-cell lung cancer F Cappuzzo, FR Hirsch, E Rossi, S Bartolini, GL Ceresoli, L Bemis, ... Journal of the National Cancer Institute 97 (9), 643-655, 2005 | 1962 | 2005 |
| A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial M Infante, S Cavuto, FR Lutman, G Brambilla, G Chiesa, G Ceresoli, ... American journal of respiratory and critical care medicine 180 (5), 445-453, 2009 | 478 | 2009 |
| Increased HER2 Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung … F Cappuzzo, M Varella-Garcia, H Shigematsu, I Domenichini, S Bartolini, ... Journal of clinical oncology 23 (22), 5007-5018, 2005 | 471 | 2005 |
| Akt phosphorylation and gefitinib efficacy in patients with advanced non–small-cell lung cancer F Cappuzzo, E Magrini, GL Ceresoli, S Bartolini, E Rossi, V Ludovini, ... Journal of the National Cancer Institute 96 (15), 1133-1141, 2004 | 455 | 2004 |
| Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial GL Ceresoli, F Cappuzzo, V Gregorc, S Bartolini, L Crino, E Villa Annals of oncology 15 (7), 1042-1047, 2004 | 424 | 2004 |
| Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management GL Ceresoli, AJM Ferreri, E Bucci, C Ripa, M Ponzoni, E Villa Cancer: Interdisciplinary International Journal of the American Cancer …, 1997 | 375 | 1997 |
| Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study T Rancati, GL Ceresoli, G Gagliardi, S Schipani, GM Cattaneo Radiotherapy and oncology 67 (3), 275-283, 2003 | 372 | 2003 |
| Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma GL Ceresoli, PA Zucali, AG Favaretto, F Grossi, P Bidoli, G Del Conte, ... Journal of clinical oncology 24 (9), 1443-1448, 2006 | 365 | 2006 |
| Gefitinib in pretreated non–small-cell lung cancer (NSCLC): Analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced … F Cappuzzo, V Gregorc, E Rossi, A Cancellieri, E Magrini, CT Paties, ... Journal of clinical oncology 21 (14), 2658-2663, 2003 | 269 | 2003 |
| Long-term outcomes and retreatment among patients with previously treated, programmed death-ligand 1‒positive, advanced non‒small-cell lung cancer in the KEYNOTE-010 study RS Herbst, EB Garon, DW Kim, BC Cho, JL Perez-Gracia, JY Han, ... Journal of Clinical Oncology 38 (14), 1580-1590, 2020 | 226 | 2020 |
| Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. GL Ceresoli, M Reni, G Chiesa, A Carretta, S Schipani, P Passoni, ... Cancer 95 (3), 605-612, 2002 | 211 | 2002 |
| Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose GL Ceresoli, A Chiti, PA Zucali, M Rodari, RF Lutman, S Salamina, ... Journal of clinical oncology 24 (28), 4587-4593, 2006 | 177 | 2006 |
| Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma GL Ceresoli, PA Zucali, F De Vincenzo, L Gianoncelli, M Simonelli, ... Lung cancer 72 (1), 73-77, 2011 | 168 | 2011 |
| EGFR overexpression in malignant pleural mesothelioma: an immunohistochemical and molecular study with clinico-pathological correlations A Destro, GL Ceresoli, M Falleni, PA Zucali, E Morenghi, P Bianchi, ... Lung cancer 51 (2), 207-215, 2006 | 161 | 2006 |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ... Annals of Oncology 27 (3), 417-423, 2016 | 160 | 2016 |
| 18-FDG positron emission tomography in the evaluation of malignant pleural diseases–a pilot study A Carretta, C Landoni, G Melloni, GL Ceresoli, A Compierchio, F Fazio, ... European journal of cardio-thoracic surgery 17 (4), 377-383, 2000 | 153 | 2000 |
| Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma GL Ceresoli, LD Locati, AJM Ferreri, C Cozzarini, P Passoni, G Melloni, ... Lung cancer 34 (2), 279-287, 2001 | 144 | 2001 |
| Advances in the biology of malignant pleural mesothelioma PA Zucali, GL Ceresoli, F De Vincenzo, M Simonelli, E Lorenzi, ... Cancer treatment reviews 37 (7), 543-558, 2011 | 142 | 2011 |
| Phase II study of asparagine-glycine-arginine–human tumor necrosis factor α, a selective vascular targeting agent, in previously treated patients with malignant pleural … V Gregorc, PA Zucali, A Santoro, GL Ceresoli, G Citterio, TM De Pas, ... Journal of Clinical Oncology 28 (15), 2604-2611, 2010 | 141 | 2010 |
| Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised … GV Scagliotti, R Gaafar, AK Nowak, T Nakano, J van Meerbeeck, S Popat, ... The Lancet Respiratory Medicine 7 (7), 569-580, 2019 | 140 | 2019 |
